This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by October 31, 2026, 11:59 PM ET.
Leading outcome
97.4%
97%
2 outcomes
Yes
No
Now Gained in 24h Lost in 24hChanges are in percentage points (pp).
Latest update
PlungeMonitoring onlyThe tracked probability fell to 96.45%, down 3.0 percentage points from 99.5% in the latest observation window. No evidence-qualified public source was supplied, so this remains a monitoring note rather than a causal explanation.
Yes: 100% → 96%
-3.0 ppOdds chart
Living timeline
Observed movement
Observed probability fell from 99.5% to 96.45% (-3.05 percentage points), from 2026-10-17T18:02:12.136Z to 2026-10-17T18:15:40.192Z (UTC).
Editorial research is deferred. This update preserves the observed market change. The cause of the move is not established.
The measured move
Yes: 99.5% → 96.45%
Probability moved from 99.5% to 96.45% (-3.05 percentage points). Observations were 13 minutes 28 seconds apart: 2026-10-17 18:02:12 UTC to 2026-10-17 18:15:40 UTC.
Watch further market observations and reporting about this contract. This update has not been enrolled for editorial research.
No external sources are attached yet.
Market rules, made readable
Official descriptionRead the rules before reading the headline. Resolution wording decides the outcome, not the news.
Resolves Yes
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by October 31, 2026, 11:59 PM ET.
Resolves No
Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
PolySays is independent and is not affiliated with, endorsed by, sponsored by, or operated by Polymarket. PolySays provides informational and educational content only and does not provide financial, betting, investment, tax, or legal advice. Prediction markets involve risk, and regulatory status varies by jurisdiction.
Source market
Figures refresh periodically, not tick by tick. PolySays explains markets; it doesn’t run one or give trading advice.
View on PolymarketPolySays may earn referral rewards from Polymarket links at no added cost to you. Full disclosure.
Story so far
MonitoringPolySays is monitoring this market.
No evidence-qualified explanation has been published yet.
No evidence logged yet. No catalyst, open question, or public source is attached to this story, and we won’t guess.